#treatment — top 20, last 30d
| 2 | ℹ |
8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.
(linkinghub.elsevier.com)
|
The Lancet 2026-09-30 | #hepatitis c #clinical trial #antiviral #treatment #viremia | |
| 0 | ℹ |
Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead.
(linkinghub.elsevier.com)
|
The Lancet 2026-09-22 | #cardiovascular #disparities #outcomes #treatment | |
| 0 | ℹ |
One year follow up outcomes of endoscopic retrograde appendicitis treatment for symptomatic appendicoliths.
(linkinghub.elsevier.com)
|
iScience 2026-09-24 | #endoscopy #appendicitis #treatment #outcomes | |
| 0 | ℹ |
Gender Differences in Hepatitis C Care Outcomes in the New York City Jail System, 2019-2023: A Retrospective Cohort Study.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-09-22 | #hepatitis #incarceration #disparities #epidemiology #treatment |